News
3h
Zacks Investment Research on MSNAMGN Down 10% in 3 Months: How to Play the Stock as Tariff Woes LingerAmgen’s AMGN stock has declined 10.4% in the past three months. A lot of this price decline is related to the broader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results